STK19-LY6G6D Fusion FISH Probe
The STK19-LY6G6D Fusion FISH Probe is used to confirm a fusion of the STK19 and LY6G6D genes. The fusion of the STK19 and LY6G6D genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| STK19-LY6G6D-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-RERE | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-REOR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-REGO | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-REGR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-OROR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GORE | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GROR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| STK19-LY6G6D-20-AQAQ | 20 (40 μL) | 200 μL |
|
STK19 Gene Summary
This gene encodes a serine/threonine kinase which localizes predominantly to the nucleus. Its specific function is unknown; it is possible that phosphorylation of this protein is involved in transcriptional regulation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6 and expresses two transcript variants. [provided by RefSeq, Jul 2008]
Gene Name: Serine/threonine Kinase 19
Chromosome: CHR6_qbl_hap6: 3232740 -3243013
Locus: 6p21.33
LY6G6D Gene Summary
LY6G6D belongs to a cluster of leukocyte antigen-6 (LY6) genes located in the major histocompatibility complex (MHC) class III region on chromosome 6. Members of the LY6 superfamily typically contain 70 to 80 amino acids, including 8 to 10 cysteines. Most LY6 proteins are attached to the cell surface by a glycosylphosphatidylinositol (GPI) anchor that is directly involved in signal transduction (Mallya et al., 2002 [PubMed 12079290]).[supplied by OMIM, Apr 2009]
Gene Name: Lymphocyte Antigen 6 Family Member G6D
Chromosome: CHR6_cox_hap2: 3192745 -3195198
Locus: 6p21.33
Gene Diseases
The STK19 LY6G6D Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|